How one company is creating a scalable biomarker for depression and anxiety
A third of the world’s population have symptoms of depression and anxiety. Mental health services were already over-stretched before 2020, but since…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.